Skip to content

Role of homoeopathic medicine in chronic urticaria

Effect of individualized homoeopathic medicines selected using kents repertory in the treatment of chronic urticaria an open label prospective clinical study - NOT AVAILABLE

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098222
Enrollment
40
Registered
2025-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L508- Other urticaria

Interventions

Intervention1: Individualized Homoeopathic Medicines: GMP certified Medicines will be prescribed after repertorisation from Kents Repertory based on case taking for every patient for a period of 6mont

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of chronic urticaria diagnosed clinically having wheals, angioedema or both for a duration exceeding 6 weeks and by blood investigations if any. 2.Patients between 18-60 years of age, from all religions, of all sexes and of different socioeconomic status. 3.Patient those who can either read or understand either Hindi or English or Bengali languages. 4.Willingness to actively participate in the study, provide written consent form.

Exclusion criteria

Exclusion criteria: 1.Currently receiving Homoeopathic treatment for any chronic condition(s). 2.Diagnosed cases of unstable mental or psychiatric illness or other systemic disease affecting quality of life. 3.Uncontrolled, unevaluated, and/or complicated diabetes mellitus, hypertension, and other comorbidities; cases with other serious systemic unevaluated or uncontrolled diseases affecting quality of life. 4.Substance abuse and/or dependence. 5.Immune-compromised states. 6.Pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
Chronic Urticaria Quality of Life questionnaireTimepoint: At baseline & after 6 months

Secondary

MeasureTime frame
Not AvailableTimepoint: Not Available

Countries

India

Contacts

Public ContactDr Birendra Prasad Srivastava

National Institute of Homoeopathy

dr.srivastava61@gmail.com9432497634

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026